AR and metastatic neoplasm: However, a significant portion of these men fail ADT after several years, resulting in castration-recurrent metastatic disease (mCRPC) that typically arises in the bone and lymph nodes, and that is largely driven by continued, often upregulated AR signaling [1, 2].